CVS Relative Valuation - CVS Health Corp

Watchlist Manager

Watchlist

Price: 71.86 USD -1.29%

Market Cap: $91.4B

	CVS Health Corp NYSE:CVS	US
	SEI Investments Co NASDAQ:SEIC	US
	Jadwa REIT Saudi Fund SAU:4342	SA

Relative Value

The Relative Value of one CVS stock under the Base Case scenario is 167.85 USD. Compared to the current market price of 71.86 USD, CVS Health Corp is Undervalued by 57%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

What is Relative Valuation?

How is Relative Value calculated?

CVS Relative Value

Base Case

Undervaluation 57%

Relative Value

Price

Worst Case

Base Case

Best Case

Valuation Multiples

View Details

Multiples Across Competitors

All Multiples

P/S

P/E

EV/EBITDA

EV/EBIT

Forward Multiples

			Market Cap	P/S	P/E	EV/EBITDA	EV/EBIT
US		CVS Health Corp NYSE:CVS	92.5B USD	0.2	51.7	13.5	13.5
US	C	Cigna Group XMUN:CGN	66.4B EUR	0.3	13.1	7.7	9.7
US		Cigna Corp NYSE:CI	70B USD	0.3	11.9	0	0
DE		Fresenius SE & Co KGaA XETRA:FRE	24.9B EUR	1.1	19.9	9.4	14
DE		Fresenius Medical Care AG XMUN:FME	22.3B EUR	1.1	22.8	8.8	16.3
US		Laboratory Corporation of America Holdings NYSE:LH	21.9B USD	1.6	25.1	12.1	17.5
US		Quest Diagnostics Inc NYSE:DGX	21.6B USD	2	21.9	11.9	16
DE	F	Fresenius Medical Care AG & Co KGaA XETRA:FME	10.6B EUR	0.5	10.9	5.3	9.8
US		Guardant Health Inc NASDAQ:GH	10.9B USD	11.1	-26.2	-28.7	-26.1
US		DaVita Inc NYSE:DVA	10.5B USD	0.8	14.1	7.2	9.8
US		Brightspring Health Services Inc NASDAQ:BTSG	8.3B USD	0	0	0	0

				Revenue Growth	P/S to Growth
US		CVS Health Corp NYSE:CVS	Average P/S: 1.9 0.2	4%	0.1
US	C	Cigna Group XMUN:CGN	0.3	6%	0
US		Cigna Corp NYSE:CI	0.3	6%	0
DE		Fresenius SE & Co KGaA XETRA:FRE	1.1	5%	0.2
DE		Fresenius Medical Care AG XMUN:FME	1.1	3%	0.4
US		Laboratory Corporation of America Holdings NYSE:LH	1.6	6%	0.3
US		Quest Diagnostics Inc NYSE:DGX	2	5%	0.4
DE	F	Fresenius Medical Care AG & Co KGaA XETRA:FME	0.5	3%	0.2
US		Guardant Health Inc NASDAQ:GH	11.1	29%	0.4
US		DaVita Inc NYSE:DVA	0.8	4%	0.2
US		Brightspring Health Services Inc NASDAQ:BTSG	Not Available	15%	N/A

				Earnings Growth	PEG
US		CVS Health Corp NYSE:CVS	Average P/E: 21.3 51.7	90%	0.6
US	C	Cigna Group XMUN:CGN	13.1	19%	0.7
US		Cigna Corp NYSE:CI	11.9	19%	0.6
DE		Fresenius SE & Co KGaA XETRA:FRE	19.9	26%	0.8
DE		Fresenius Medical Care AG XMUN:FME	22.8	16%	1.4
US		Laboratory Corporation of America Holdings NYSE:LH	25.1	27%	0.9
US		Quest Diagnostics Inc NYSE:DGX	21.9	12%	1.8
DE	F	Fresenius Medical Care AG & Co KGaA XETRA:FME	10.9	16%	0.7
US		Guardant Health Inc NASDAQ:GH	Negative Multiple: -26.2	N/A	N/A
US		DaVita Inc NYSE:DVA	14.1	20%	0.7
US		Brightspring Health Services Inc NASDAQ:BTSG	Not Available	30%	N/A

				EBITDA Growth	EV/EBITDA to Growth
US		CVS Health Corp NYSE:CVS	Average EV/EBITDA: 9.5 13.5	28%	0.5
US	C	Cigna Group XMUN:CGN	7.7	4%	1.9
US		Cigna Corp NYSE:CI	Not Available	N/A	N/A
DE		Fresenius SE & Co KGaA XETRA:FRE	9.4	10%	0.9
DE		Fresenius Medical Care AG XMUN:FME	8.8	7%	1.3
US		Laboratory Corporation of America Holdings NYSE:LH	12.1	10%	1.2
US		Quest Diagnostics Inc NYSE:DGX	11.9	6%	2
DE	F	Fresenius Medical Care AG & Co KGaA XETRA:FME	5.3	7%	0.8
US		Guardant Health Inc NASDAQ:GH	Negative Multiple: -28.7	N/A	N/A
US		DaVita Inc NYSE:DVA	7.2	4%	1.8
US		Brightspring Health Services Inc NASDAQ:BTSG	Not Available	31%	N/A

				EBIT Growth	EV/EBIT to Growth
US		CVS Health Corp NYSE:CVS	Average EV/EBIT: 13.3 13.5	22%	0.6
US	C	Cigna Group XMUN:CGN	9.7	5%	1.9
US		Cigna Corp NYSE:CI	Not Available	N/A	N/A
DE		Fresenius SE & Co KGaA XETRA:FRE	14	12%	1.2
DE		Fresenius Medical Care AG XMUN:FME	16.3	11%	1.5
US		Laboratory Corporation of America Holdings NYSE:LH	17.5	18%	1
US		Quest Diagnostics Inc NYSE:DGX	16	9%	1.8
DE	F	Fresenius Medical Care AG & Co KGaA XETRA:FME	9.8	11%	0.9
US		Guardant Health Inc NASDAQ:GH	Negative Multiple: -26.1	N/A	N/A
US		DaVita Inc NYSE:DVA	9.8	5%	2
US		Brightspring Health Services Inc NASDAQ:BTSG	Not Available	43%	N/A

CVS Health Corp
NYSE:CVS

Relative Value

Valuation Multiples

Multiples Across Competitors

CVS Competitors Multiples
CVS Health Corp Competitors

See Also

Company

Help

Tools

Stocks

CVS Health Corp NYSE:CVS

Relative Value

Valuation Multiples

Multiples Across Competitors

CVS Competitors Multiples CVS Health Corp Competitors

See Also

Company

Help

Tools

Stocks

CVS Health Corp
NYSE:CVS

CVS Competitors Multiples
CVS Health Corp Competitors